PCM
TWST icon

Peregrine Capital Management’s Twist Bioscience TWST Stock Holding History

Peregrine Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Sell
138,970
-81,109
-37% -$5.28M 0.46% 46
2026
Q1 		$10.5M Sell
220,079
-68,204
-24% -$3.06M 0.39% 64
2025
Q4 		$9.14M Sell
288,283
-3,870
-1% -$121K 0.28% 100
2025
Q3 		$8.22M Buy
292,153
+75,571
+35% +$2.29M 0.25% 111
2025
Q2 		$7.97M Buy
+216,582
New +$7.48M 0.24% 118

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Peregrine Capital Management's TWST Position: Q2 2026 in Review

Peregrine Capital Management reduced its Twist Bioscience (TWST) stake by 37% in Q2 2026, selling an estimated $5.28M and leaving 138,970 shares worth $14.3M. The position accounts for 0.46% of the portfolio, ranked #46.

Peregrine Capital Management first reported a position in TWST in Q2 2025 and has held it in 5 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Peregrine Capital Management held 138,970 shares of Twist Bioscience worth $14.3M as of Q2 2026.
  • Peregrine Capital Management sold 81,109 Twist Bioscience shares in Q2 2026, an estimated $5.28M.
  • Twist Bioscience made up 0.46% of Peregrine Capital Management's portfolio in Q2 2026, its #46 holding.
  • Peregrine Capital Management first reported a position in Twist Bioscience in Q2 2025 and has held it in 5 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.